408328-18-7

Basic information

• Product Name: 5-bromo-3-nitro-2,4-pyridinediol
• Synonyms: 5-bromo-3-nitro-2,4-pyridinediol
• CAS NO: 408328-18-7
• Molecular Formula: C5H3BrN2O4
• Molecular Weight: 234.99232
• Mol File: 408328-18-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-bromo-3-nitro-2,4-pyridinediol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-3-nitro-2,4-pyridinediol(408328-18-7)
• EPA Substance Registry System: 5-bromo-3-nitro-2,4-pyridinediol(408328-18-7)

Safety Data

• Hazardous Substances Data: 408328-18-7(Hazardous Substances Data)

Upstream product

• 96245-97-5 3-bromo-2,4-dihydroxypyridine 
• 7697-37-2 nitric acid 
• 89282-12-2 2,4-dihydroxy-3-nitropyridine 
• 80791-79-3 5-bromo-pyridine-2,4-diol 

Downstream Products

• 503425-84-1 5-bromo-2,4-dichloro-[3]pyridylamine 
• 873397-71-8 5-bromo-2,3,4-trichloro-pyridine 
• 1590410-22-2 C₁₂H₉BrClN₃O₂ 
• 1590410-24-4 C₁₂H₁₁BrClN₃ 
• 1590410-82-4 C₁₃H₁₀BrN₃O 
• 1334136-60-5 5-bromo-2-chloro-3-nitropyridin-4-amine 
• 856850-68-5 5-bromo-2,4-dichloro-3-nitro-pyridine 

Relevant articles and documents

Medicine composition for treating fatty liver and preparation method thereof

The invention relates to a medical composition for treating a fatty liver. The medical composition is a compound comprising the following structural formula as shown in the description. The inventionfurther relates to a preparation method of the medical composition. The medical composition can reduce TC, TG, AST, ALT, ALP and LDL-C of serum of rats suffering from the fatty liver, and can eliminate accumulation of part of fat in liver cells. The effect of the medical composition on improvement on the fatty liver is similar with acipimox. Compared with a model group, the SOD vitality and the MDA level of dose groups of the medical composition disclosed by the invention is slightly improved. The medical composition has a certain effect of reducing fat and protecting liver, and is hopeful tobe a new medicine clinically.

ANTI-FIBROTIC PYRIDINONES

Disclosed are pyridinone compounds, method for preparing these compounds, and methods for treating fibrotic disorders.